In patients with high triacylglycerol levels and low HDL-cholesterol , fenofibrate reduced total cardiovascular outcomes by @ % ( @ % CI -@ % , @ % ) in women and @ % ( @ % CI @ % , @ % ) in men , with no treatment-by-sex interaction ( p > @ ) .